Bozó E, Boros S, Párkányi L, Kuszmann J
Gedeon Richter Chemical Works Ltd., Budapest, Hungary.
Carbohydr Res. 2000 Nov 3;329(2):269-86. doi: 10.1016/s0008-6215(00)00190-7.
Treatment of 1,6:2,5-dianhydro-3,4-di-O-methanesulfonyl-1-thio-D-glucitol in methanol with sodium hydroxide afforded 1,6:2,5:3,4-trianhydro-1-thio-allitol, 1,4:2,5-dianhydro-6-methoxy-1-thio-D-galactitol, 1,6:2,5-dianhydro-4-O-methyl-1 -thio-D-glucitol, 1 ,6:2,5-dianhydro-3-O-methanesulfonyl-1 -thio-D-glucitol and 1 ,6:2,5-dianhydro-4-deoxy-1-thio-D-erythro-hex-3-ulose (14) in 5, 4, 28, 5.5 and 41% yield, respectively. Formation of these derivatives can be explained via a common sulfonium intermediate. Reduction of 14 with sodium borohydride and subsequent acetylation afforded 3-O-acetyl-1,6:2,5-dianhydro-4-deoxy-1-thio-D-xylo-hexitol, the absolute configuration of which was proved by X-ray crystallography. The 1,6:2,5-dianhydro-1-thio-D-hexitol derivatives in which the free OH groups were protected by acetylation, methylation or mesylation were converted by a Pummerer reaction of their sulfoxides into the corresponding 1-O-acetyl hexoseptanose derivatives which were used as donors for the glycosidation of 4-cyano- and 4-nitrobenzenethiol, respectively. The Pummerer reaction of 1,6:2,5-dianhydro-4-deoxy-3-O-methyl-1-thio-D-xylo-hexitol S-oxide gave, besides 1-O-acetyl-2,5-anhydro-3-deoxy-4-O-methyl-6-thio-alpha-L- (23) and 1-O-acetyl-2,5-anhydro-4-deoxy-3-O-methyl-6-thio-alpha-D-xylo-hexoseptanose (25), 1-O-acetyl-4-deoxy-2,6-thioanhydro-D-lyxo-hexopyranose, formed in a rearrangement reaction. The same rearrangement took place, when a mixture of 23 and 25 was used as donor in the glycosidation reaction with 4-cyanobenzenethiol, applying trimethylsilyl triflate as promoter. The oral antithrombotic activity of the obtained alpha-thioglycosides was determined in rats, using Pescador's model.
在甲醇中用氢氧化钠处理1,6:2,5 - 二脱水 - 3,4 - 二 - O - 甲磺酰基 - 1 - 硫代 - D - 葡萄糖醇,分别以5%、4%、28%、5.5%和41%的产率得到1,6:2,5:3,4 - 三脱水 - 1 - 硫代 - 阿洛糖醇、1,4:2,5 - 二脱水 - 6 - O - 甲基 - 1 - 硫代 - D - 半乳糖醇、1,6:2,5 - 二脱水 - 4 - O - 甲基 - 1 - 硫代 - D - 葡萄糖醇、1,6:2,5 - 二脱水 - 3 - O - 甲磺酰基 - 1 - 硫代 - D - 葡萄糖醇和1,6:2,5 - 二脱水 - 4 - 脱氧 - 1 - 硫代 - D - 赤藓糖 - 己 - 3 - 酮糖(14)。这些衍生物的形成可通过一个共同的锍中间体来解释。用硼氢化钠还原14并随后乙酰化,得到3 - O - 乙酰基 - 1,6:2,5 - 二脱水 - 4 - 脱氧 - 1 - 硫代 - D - 木糖 - 己糖醇,其绝对构型通过X射线晶体学得以证实。其中游离羟基通过乙酰化、甲基化或甲磺酰化保护的1,6:2,5 - 二脱水 - 1 - 硫代 - D - 己糖醇衍生物,通过其亚砜的Pummerer反应转化为相应的1 - O - 乙酰基己糖七环糖衍生物,分别用作4 - 氰基苯硫酚和4 - 硝基苯硫酚糖苷化的供体。1,6:2,5 - 二脱水 - 4 - 脱氧 - 3 - O - 甲基 - 1 - 硫代 - D - 木糖 - 己糖醇S - 氧化物的Pummerer反应,除了得到1 - O - 乙酰基 - 2,5 - 脱水 - 3 - 脱氧 - 4 - O - 甲基 - 6 - 硫代 - α - L -(23)和1 - O - 乙酰基 - 2,5 - 脱水 - 4 - 脱氧 - 3 - O - 甲基 - 6 - 硫代 - α - D - 木糖 - 己糖七环糖(25)外还得到了在重排反应中形成的1 - O - 乙酰基 - 4 - 脱氧 - 2,6 - 硫代脱水 - D - 来苏糖 - 己吡喃糖。当将23和25的混合物用作与4 - 氰基苯硫酚糖苷化反应的供体并使用三氟甲磺酸三甲基硅酯作为促进剂时,发生了相同的重排反应。使用佩斯卡多模型在大鼠中测定了所得到的α - 硫代糖苷的口服抗血栓活性。